To advance science relevant to transplants, this bill would also:
Seek to reinvigorate the federal Advisory Council on Blood Stem Cell Transplantation, which provides expert recommendations on issues impacting the timely delivery of bone marrow, cord blood, and peripheral blood stem cells to patients in need of transplants; and
Require the Dept. of Health and Human Services (HHS) to review the state of the science related to regenerative medicine for the purpose of potentially including these innovative therapies in the outcomes database for the C.W. Bill Young Cell Transplantation Program.
The HHS review, which would occur at least once every two years, would also include investigating the use of adult stem cells and birthing tissue for research and development of new therapies.